Wednesday, August 8, 2007
4:30 p.m. EDT
TORONTO, Aug. 7 /CNW/ - NUCRYST Pharmaceuticals Corp. will hold a webcast
at 4:30 p.m. EDT on Wednesday, August 8, 2007 regarding the company's 2007
second quarter results.
In addition to standard disclosure over wire services, a news release and
financial statements will be posted on the NUCRYST web site. To listen to the
call live on the Internet, please go to www.nucryst.com.
Scott H. Gillis, President & CEO and Eliot M. Lurier, Vice President,
Finance & Administration and Chief Financial Officer will participate on the
An audio file of the call will be archived and posted on the NUCRYST web
NUCRYST Pharmaceuticals (NASDAQ: NCST; TSX: NCS) develops, manufactures
and commercializes medical products that fight infection and inflammation
using its patented atomically disordered nanocrystalline silver technology.
Smith & Nephew plc sell a range of advanced wound care products under their
Acticoat(TM) trade mark: Acticoat(TM) products incorporate NUCRYST's
SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also
developing pharmaceutical products to address medical conditions that are
characterized by both infection and inflammation. The Company has developed
its proprietary nanocrystalline silver in a powder form for use as an active
pharmaceutical ingredient, referred to as NPI 32101.
For further information:
For further information: Gillian McArdle, (416) 504-8464,